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Screening of lactic acid bacteria (LAB) isolated from ewe colostrum led to the
identification and isolation of Enterococcus faecium CM33 with interesting features like
high survival rates under acidic or bile salts condition, high tolerance for the simulated
gastrointestinal condition, and high adhesive potential to Caco-2 cells. According
the inhibition of pathogen adhesion test results, this strain can reduce more than
50% adhesion capacity of Escherichia coli, Shigella flexneri, Klebsiella pneumoniae,
Listeria monocytogenes, and Staphylococcus aureus to Caco-2 cells. Based on the
antibiotic sensitivity test findings, E. faecium CM33 was susceptible to gentamycin,
vancomycin, erythromycin, ampicillin, penicillin, tetracycline, and rifampicin, but resistant
to chloramphenicol, clindamycin, and kanamycin. Upon assessment of the virulence
determinants for E. faecium CM33, this strain was negative for all tested virulence genes.
Furthermore, the genome of this strain was evaluated for the incidence of the known
enterocin genes by specific PCR amplification and discovered the genes encoding
enterocins A, 31, X, and Q. Based on this study findings, the strain E. faecium CM33
can be considered as a valuable nutraceutical and can be introduced as a new potential
probiotic.
Keywords: antimicrobial activity, Enterococcus faecium, enterocins, probiotic, virulence genes
Introduction
The health promoting eﬀects of probiotic bacteria are strain-speciﬁc, hence their discrimination
and identiﬁcation is very important and crucial under strain level by applying an eﬃcient and
valid strain-identiﬁcation techniques such as 16S rRNA sequencing. Besides, some identiﬁcation
methods can be utilized for assessment on the safety aspect and ecological properties of probiotics
(Pereira and Gibson, 2002; Senok, 2009). The choice of appropriate probiotics is the most
important base for enhancing the bio-therapeutic achievement in nutraceutical/pharmaceutical
products. Several important characters of bacteria used as probiotics are the ability to survive in
gastric conditions and adhere to the host intestinal cells (Kirjavainen et al., 1998; Dunne et al.,
2001). However, in vitro procedures for choice of promising probiotics are necessary because
in vivomethods are costly and need agreement by ethical committees.
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Caco-2 cells have been eﬀectively applied to ﬁnd the
mechanism of cellular adhesion of non-pathogenic lactic acid
bacteria (LAB; Tuomola and Salminen, 1998). It has also been
explained that enterococci produce antimicrobial substances
such as bacteriocins, hydrogen peroxide, and lactic acid (Sparo
et al., 2006; Franz et al., 2007), which could elucidate their
ability against several pathogens such as Staphylococcus aureus
and Listeria monocytogenes. The connection of Enterococcus
bacteria with human diseases has raised concern regarding their
use as probiotic microorganisms (Franz et al., 2011). Several
enterococcal strains are able to have antiviral activity (Wang
et al., 2013), beneﬁcial eﬀects in anti-tumoral protective responses
(Thirabunyanon and Hongwittayakorn, 2013) and can restore
the microbiota balance in antibiotic-induced dysbiosis (Tarasova
et al., 2010). Enterococcus bacteria, utilized in fermentation of
vegetable products, meat, and dairy, are the reason of clinical
infections. Therefore, it is vital to evaluate the virulence genes as
well the antibiotic resistance proﬁle.
Although the safety aspect of this genus is still blurred,
members of enterococci are now engaged as probiotic bacteria
to improve the immunity and human health (Brandão et al.,
2010). The capability of these bacteria to make enterocins is
remarkable and can be applied as food bio-preservatives (Khan
et al., 2010). Bacteriocins are small, ribosomally synthesized
and heat-stable peptides that apply antimicrobial activity against
pathogenic bacteria or food spoilage, including Staphylococcus
aureus, Clostridium spp. Bacillus spp., L. monocytogenes, and
Campylobacter spp. (Nes et al., 2007; Line et al., 2008). Franz
et al. (2007) categorized bacteriocins produced by Enterococcus
bacteria into four diﬀerent classes: Class I is lantibiotic enterocins
such as cytolysin (CylLL/S; Gilmore et al., 1994); Class II is
small, non-lantibiotic enterocins; Class III is cyclic enterocins
for instance enterocin AS-48 (Eijsink et al., 2002); and Class IV
is large proteins like enterolysin A (Hickey et al., 2003). There
are three subclasses within class II including subclass IIa such as
enterocin A and P (Ent A and Ent P), which are pediocin-like
bacteriocins; subclass IIb like enterocin L50 and Q (Ent L50A/B
and Ent Q), which required two peptides for full antimicrobial
activity and subclass IIc like enterocin B (Ent B), which are
other linear and non-pediocin-type enterocins (Casaus et al.,
1997).
Although there are rising concern about the safety of
Enterococcus bacteria because of their relationship with several
human infections (Brandão et al., 2010), a lot of works specify
that enterococci play a key function in the improvement of the
sensory properties of fermented foods like olives, sausages and
cheese (Moreno et al., 2006). Carlos et al. (2010) elucidated a
lot of virulence factors and their actions in Enterococcus bacteria
(Carlos et al., 2010). These include the cylA which is in charge of
the transportation and activation of the cytolisin; cylB and cylM
involved in the post-translational modiﬁcation; esp gene in charge
of a cell wall protein involved in immune evasion; agg encodes
an aggregation protein which is responsible for adherence to
eukaryotic cells; gelE is in charge of toxin production that
hydrolyzes gelatine and other compounds, and ﬁnally cpd, ccf,
and cad genes encode sex pheromones, which are in charge of
facilitating conjugation.
Because of the high potential of Enterococcus bacteria in health
and food, the purpose of current study was to ﬁnd out the
antimicrobial activity and the presence of bacteriocin structural
genes and virulence factors in Enterococcus faecium CM33
isolated from ewe colostrum to assess the potential probiotic
properties and safety aspect of use of this strain.
Materials and Methods
Bacteria Isolation
Enterococcus faecium CM33 was isolated from ewe colostrum
by culturing in de Man Rogosa and Sharpe broth (MRS) and
following incubation of 50µl of cultured medium onto MRS agar
supplemented with 6.5% (w/v) NaCl (MRS-NaCl) for 18 h at 37◦C
in aerobic conditions. After enrichment, ﬁve passages by isolated
colony, the pure bacterium isolate was obtained.
PCR Amplification of Isolate
The ampliﬁcation of 16S rRNA gene (1500 bp) of the
isolate was performed by the primers (F 5′-AGAGTTTGATC
CTGGCTCAG-3′ and R 5′-GGCTGCTGGCACGTAGTTAG-
3′), which those primarily used by Kullen et al. (2000).
The ampliﬁcation reaction was performed in a thermocycler
(Thermo Electron Corporation, Waltham, MA, USA) with the
following thermocycle program: Four min at 96◦C as an initial
denaturation; 30 s at 96◦C as a denaturation for 30 cycles; 30 s at
48◦C as an annealing and 45 s at 72 C as an extension, with a ﬁnal
extension step for 4 min at 72◦C. The total volume of reaction
was 50 µl. The PCR product was visualized through 0.8% (w/v)
agarose gel (Sigma Chemical Co., Poole, UK) electrophoresis
by using ethidium bromide staining (Kullen et al., 2000). PCR
product was sequenced by the Macrogen DNA Sequencing
Service (Korea). The sequence was interrogated through the
BLAST search of the NCBI database. The isolate was identiﬁed
on account of the highest matching score.
Effects of Heat, pH, and Hydrolytic Enzymes
This strain was cultured in MRS broth for 18 h at 37◦C.
After 10 min centrifugation at 12000 g, cells were removed
and the cell free supernatant (metabolites) was utilized for
additional characterization. To determine the eﬀect of pH on the
metabolites action, pH of the crude supernatant was adjusted
in the range between 1.5 and 9 by adding sterile 1 M HCl or
1 M NaOH. Sample was incubated at room temperature for
4 h. Thermostability of metabolites was determined at diverse
temperatures. Crude supernatant was autoclaved at 121◦C for
15 min and then incubated at diﬀerent temperatures (4, −20,
and −70C) for 24 h, 48 h, 2 weeks, and 1 month.
The sensitivity of cell free supernatant toward diﬀerent
proteolytic enzymes, amylase, and catalase was investigated. One
mg/ml of enzymes including proteinase K, pronase E, trypsin,
and chymotrypsin were prepared in 15 mM sodium phosphate
buﬀer (pH 7.2) and pepsin was prepared in glycine buﬀer
pH 2. Before incubating for 2 h at 37◦C, proteases at a ﬁnal
concentration of 0.1 mg/ml were added. The crude cell free
supernatant was treated with catalase at 0.1 mg/ml to remove
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potential inhibitory eﬀects because of production of hydrogen
peroxide.
Targeting Bacteriocin Genes
To detect genes encoding the known enterocins, genomic DNA
of strain CM33 was used as template. PCR were performed in a
Hybrid PCR Sprint thermocycler (Thermo Electron Corporation,
Waltham, MA, USA) in 20 ml reaction mixture (10 pmoles of
each primer, 1 mL DNA template, and 1.25 U Taq polymerase).
The PCR conditions for enterocin-encoded genes are illustrated
in Table 1. The PCR products were visualized by electrophoresis
in 1.5% agarose gels.
Bile Tolerance Test
The method previously described by Pereira and Gibson (2002)
was used to measure the viability of strain in bile salt. The isolate
was grown inMRSmedium supplemented with 0.5% (w/v) oxgall
then was incubated for 4 h at 37◦C. To determine of cell count,
aliquots were plated onto MRS-agar medium at times 0, 1, 3,
and 4 h. Control tube was without bile salt (Pereira and Gibson,
2002).
Survivability in Simulated In Vitro Digestion
Simulated in vitro digestion was carried out to evaluate the
survival rate of strain CM33 in similar condition of the human
gastrointestinal tract. To simulate the stomach digestion, samples
(pH 3.0) were treated with 5% (w/v) pepsin (Sigma Chemical Co.,
Poole, UK) then were incubated for 120 min at 37◦C with gentle
agitation. The intestinal digestion was simulated by inoculating
solutions of 0.1% (w/v) pancreatin (Sigma Chemical Co., Poole,
UK) and 0.3% (w/v) bile oxgall. The samples were incubated for
180 min at 37◦C with gentle shaking. Samples were removed
before and after gastric and intestinal digestion to measure cell
count. The serially diluted aliquots were cultured on MRS agar
medium and were incubated for 24 h under anaerobic conditions
(Seiquer et al., 2001).
Adhesion Ability to Caco-2 Cells
Caco-2, the colon adenocarcinoma cell line, was used to evaluate
the adhesion ability of E. faeciumCM33 to human epithelial cells.
RPMI medium supplemented with 10% (v/v) fetal bovine serum
and 1% (v/v) penicillin/streptomycin mixture (Sigma Chemical
Co., Poole, UK) was used to culture human colon cancer cells.
Cells were seeded on 24-well tissue culture plates and incubated at
37◦C in 5%CO2 in a humidiﬁed atmosphere. Before the adhesion
assay, fresh antibiotic-free RPMI was used to wash wells, which
have a monolayer of Caco-2 cells. Then, each well was inoculated
with 1 × 107 cfu/ml of E. faecium in a total volume of 1 ml and
incubated at 37◦C for 3 h in an atmosphere of 5% (v/v) CO2. The
wells were washed thrice with a pre-warmed phosphate buﬀer
saline (Sigma Chemical Co., Poole, UK) to remove non-attached
cells of E. faecium. To detach the cells, 1 ml of 1% Triton X-100
(Sigma Chemical Co., Poole, UK) was added to each well with
gently stirring for 5–10 min and then the viable human colon
cancer cells, Caco-2, were counted. Finally, bacteria and Caco-2
cells were cultured onto MRS agar by the pure plate method and
incubated at 37◦C anaerobically. The total number of bacteria
attached to viable Caco-2 cells expressed as bacterial adhesion
and carried out in triplicate.
Inhibition of Pathogen Adhesion to Caco-2
cells
Caco-2, human colon cells, were used to assess the eﬀect
of E. faecium treatment on the pathogen interaction with
cells. E. faecium and pathogens (Escherichia coli, S. ﬂexneri,
K. pneumonia, and S. aureus) were cultured in MRS and LB,
respectively. Overnight culture of E. faecium and pathogens
were harvested and washed thrice with phosphate buﬀer saline.
Bacteria were diluted in antibiotic-free RPMI and 0.5 ml/well
(108 CFU per well) of E. faecium suspension was inoculated
to 24-well tissue culture plates. To evaluate the capability of
E. faecium to restrain pathogenic bacteria adhesion to Caco-
2 cells, simultaneous addition of 108 CFU per well of tested
TABLE 1 | Primer sequences for PCR amplification of enterocin genes in Enterococcus faecium CM33.
Genes Primers Sequences 5′→3′ Size (bp) Tm (◦C) PCR
amplification
Reference
A
B
P
X
31
Q
AS48
Cyl
L50A
EntA-F
EntA-R
EntB-F
EntB-R
P-F
P-R
EntX-F
EntX-R
Ent31-F
Ent31-R
EntQ-F
EntQ-R
EntAS48-F
EntAS48-R
Cyl-F
Cyl-R
EntL50-F
EntL50-R
AAATATTATGGAAATGGAGTGTAT
CTCGTTAAGGTCCCTTCACG
CAAAATGTAAAAGAATTAAGTACG
AGAGTATACATTTGCTAACCC
GCTACGCGTTCATATGGTAATGGT
ATGTCCCATACCTGCCAAACCAGAAGC
GTTTCTGTAAAAGAGATGAAAC
CATACCAATTACTAATTCTCC
CCTACGTATTACGGAAATGGT
GCCATGTTGTACCCAACCATT
CAAGAAATTTTTTCCCATGGC
ACGCTATGGTAAAAATTCTTC
GAGGAGTTTCATGATTTAAAG
CGAACCATTAAATTGTTATAC
GGCGGTATTTTTACTGGAGTN
CCTACTCCTAAGCCTATGGTA
GGAGCAATCGCAAAATTAG
TAACCTCTTCCTACCCGTTA
475
201
132
500
130
95
185
248
150
56
56
60
50
58
55
50
58
55
–
–
–
+
+
+
–
+
–
Du Toit et al. (2000)
De Vuyst et al. (2003)
Cintas et al. (2000)
Edalatian et al. (2012)
De Vuyst et al. (2003)
Citti et al. (2002)
Du Toit et al. (2000)
De Vuyst et al. (2003)
Du Toit et al. (2000)
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pathogens was performed separately. Plates were incubated 1 h
at 37◦C and washed twice with sterile PBS then 1% (v/v) Triton
X-100 (Sigma Chemical Co., Poole, UK) in deionized water for
5 min was used to lyse the cell-associated pathogens. To ﬁnd
out the number of viable cell-linked bacteria by colony forming
counts, the suitable dilutions of the lysate were placed on LB agar.
The inhibition analysis was calculated in three independent trials
and each experiment was carried out in triplicate.
Antimicrobial Activity
To determine and identify inhibitory substances of metabolites
produced by E. faecium CM33, well-diﬀusion method was
performed (Hechard et al., 1990). Overnight cultures of the
indicator strains were cultured in MRS agar at 37◦C for 18 h.
50µl of ﬁltered crude supernatant of CM33were dropped to each
well (5 mm) into agar plates. The suspensions were inoculated to
the wells and permitted to diﬀuse for 4 h at room temperature
into MRS agar. The inhibition zone produced around the
wells was determined after 24 h incubation at the optimum
growth temperature of the indicator strains. The diameter of the
produced inhibition zones around the wells was determined by
digital caliper. These diameters were classiﬁed to four diﬀerent
groups including no inhibition (–), weak (+), good (++), and
strong (+++). All trials were carried out in triplicate.
PCR Detection of Virulence Factors in
Enterococci
Detection of genes encoding potential virulence factors in
E. faecium CM33 was performed by PCR. Total bacterial DNA
used as template in PCR reactions was isolated by the alkaline
lysis method (Baele et al., 2001). Virulence genes evaluated in
this study include: cytolysin (CylA, CylB, CylM; Semedo et al.,
2003; Vankerckhoven et al., 2004), enterococcal surface protein
(esp; Vankerckhoven et al., 2004), collagen-binding protein (ace;
Omar et al., 2004), gelatinase (gelE), aggregation substance (agg;
Eaton and Gasson, 2001; Ahmed et al., 2012), sex pheromone
peptides (cpd; Abriouel et al., 2008), cell-wall anchored collagen
adhesion (acm; Cariolato et al., 2008; Nallapareddy et al., 2008),
and van A, van B, van C2 (Satake et al., 1997). E. faecium ATCC
51299 and ATCC 29212 were controls for this test. PCR was used
to detect of genes encoding these factors using several primers
(Table 2) which have been described by Eaton and Gasson
(2001).
Interpretation of Results
Data were analyzed using SPSS 19.0 software (SPSS Inc., an IBM
Company, Schaumburg, IL, USA). One-way ANOVA followed
by multiple mean comparisons Duncan’s test were used to assess
statistical diﬀerences in multiple groups. Values are mean ± SE
and p ≤ 0.05 is considered statistically signiﬁcant.
Results
Bacteria Isolation
Screening of diﬀerent dairy products like colostrum, yogurt,
curd, cheese, and yogurt drink led to the isolation of E. faecium
CM33 from ewe colostrum. After DNA extraction, the 16S rRNA
fragments were ampliﬁed by PCR. According to 16S rRNA
identiﬁcation, 50 of the isolated bacteria were classiﬁed into three
major groups of LAB, namely, 14% enterococci, 66% lactobacilli,
and 20% lactococci. The isolates classiﬁed as LAB were also
TABLE 2 | Primers used for screening of virulence factors genes.
Gene Primer Sequence 5′→3′ Product size
(bp)
Reference
CylA cytI
cytIIb
ACTCGGGGATTGATAGGC
GCTGCTAAAGCTGCGCTT
688 Vankerckhoven et al. (2004)
CylB cytB1
cytB2
AAGTACACTAGTAGAACTAAGGGA
ACAGTGAACGATATAACTCGCTATT
2020 Semedo et al. (2003)
CylM cylM1
cylM2
AAAAGGAGTGCTTACATGGAAGAT
CATAACCCACACCACTGATTCC
2940 Semedo et al. (2003)
esp esp14F
esp12R
AGATTTCATCTTTGATTCTTGG
AATTGATTCTTTAGCATCTGG
510 Vankerckhoven et al. (2004)
ace ace-F
ace-R
GAATTGAGCAAAAGTTCAATCG
GTCTGTCTTTTCACTTGTTTC
1008 Ben Omar et al. (2008)
gelE gelE-F
gelE-R
ACCCCGTATCATTGGTTT
ACGCATTGCTTTTCCATC
419 Reviriego et al. (2005)
agg agg-F
agg-R
AAGAAAAAGAAGTAGACCAAC
AAACGGCAAGACAAGTAAATA
1553 Eaton and Gasson (2001)
cpd cpd-F
cpd-R
TGGTGGGTTATTTTTCAATTC
TACGGCTCTGGCTTACTA
782 Reviriego et al. (2005)
van A van C2-1
van C2-2
CGGGGAAGATGGCAGTAT
CGCAGGGACGGTGATTTT
732 Satake et al. (1997)
van B van C2-1
van C2-2
CGGGGAAGATGGCAGTAT
CGCAGGGACGGTGATTTT
635 Satake et al. (1997)
van C2 van C2-1
van C2-2
CGGGGAAGATGGCAGTAT
CGCAGGGACGGTGATTTT
484 Satake et al. (1997)
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separated and identiﬁed by sequencing. After sequencing, the
Enterococcus strains were categorized into E. lactis, E. hirae,
E. avium, E. durans, E. faecalis, and E. faecium. The Lactobacillus
strains representing 66% were classiﬁed into L. acidophilus
and L. plantarum. The Lactococcus species were classiﬁed only
into one species (Lactococcus lactis). Probiotic characterization
of these isolates showed that E. faecium CM33 has the best
properties such as tolerance to acid and bile, antimicrobial
activity and antibiotic resistance thus it was selected for further
analysis.
Effects of pH, Heat, and Hydrolytic Enzymes
on E. faecium Bacteriocin
The stability and activity of E. faecium CM33 bacteriocins has
been shown in Table 3. Bacteriocins were active over broad
ranges of pH from 1.5 to 9. It was also stable after autoclaving
at 121◦C for 15 min. The treatment of cell free supernatant of
E. faecium CM33 with amylase, catalase, and proteolytic enzymes
showed that amylase and catalase enzymes do not inﬂuence on
the bacteriocin activity, while proteolysis enzymes aﬀect on the
bacteriocin activity after 2 h.
PCR Analysis of Bacteriocin Genes
PCR ampliﬁcation using speciﬁc primers as shown inTable 1 was
used to screen DNA of E. faecium CM33 for the existence of the
known enterocin genes. This study focused on enterocin genes
including Cyl, A, P, 31, Q, X, L50A, and AS-48. E. faecium CM33
showed four bands: 95, 130, 248, and 500 bp corresponding
to the speciﬁc ampliﬁcation of enterocins Q, 31, Cyl, and X,
respectively.
Survivability in Bile Salt and Simulated
Digestion
Enterococcus faecium CM33 was incubated in 0.3% bile salts for
4 h. It showed the survival rate of >93% after this incubation
period. One of the most desirable features needed for probiotics
is the ability to survive in the GI tract. For further analysis,
E. faecium CM33 was evaluated using simulated digestion
test. This test revealed that this strain had 57.6% digestion
survivability.
TABLE 3 | Effects of pH, heat, and enzymes (concentration 1 mg/ml) on
the antibacterial activity present in E. faecium CM33 culture metabolites.
Treatments Antibacterial activity
pH
1.5–9
Heat
121◦C for 15 min
Enzymes
Pepsin
Trypsin
Chymotrypsin
Proteinase K
Pronase E
Catalase
Amylase
+
+
–
–
–
+
+
–
–
Adhesion Assay to Caco-2 Cells
The strain was tested further for its capability to colonize Caco-
2 cells. E. faecium CM33 showed the acceptable adhesion ability
with an adhesion value of 32 × 104 cfu/ml. E. faecium ATCC
29212, which used as a control to compare their adhesion ability,
could not signiﬁcantly adhere to Caco-2 cells.
Inhibition of Pathogens Adhesion
In the presence of E. faecium CM33, the inhibition of pathogens
adhesion was presented in Table 4. All the adherent pathogens
were clearly reduced by co-culture with E. faecium. The reduction
of E. coli, S. ﬂexneri, K. pneumoniae, and S. aureus adhesion to
Caco-2 cells was more than 50% added with E. faecium 108 CFU
per well.
Antimicrobial Activity
The strain CM33 isolated from colostrum displayed
antimicrobial activity against all the tested indicator
microorganisms (Table 5). The most sensitive indicators
were L. monocytogenes, followed by Candida albicans. On
the contrary, Clostridium diﬃcile, Clostridium histolyticum,
Salmonella typhimurium, and Streptococcus mutans were the less
sensitive indicator microorganisms.
Virulence Genes
The presence of virulence genes in genomic DNA of E. faecium
CM33 was screened by PCR. Currently several enterococci are
being used as probiotics but they should be carefully assessed to
ensure that they are not pathogenic. E. faecium CM33 was found
to be negative for all tested virulent genes (Table 6). In the case
of van A, van B and van C2 genes, it is essential to note that this
result associate with the lack of resistance to vancomycin.
Discussion
The food industry is requested to present increasingly functional
foods containing beneﬁcial components because of the great
TABLE 4 | Inhibition of pathogens adhesion by co-culture with E. faecium
CM33.
Pathogens Adhesive pathogen count (105 CFU ml−1)
Untreated Co-cultured
Clostridium difficile
Clostridium histolyticum
Staphylococcus aureus
Staphylococcus saprophyticus
Salmonella typhimurium
Candida albicans
Escherichia coli 0157
Bacillus cereus
Listeria monocytogenes
Klebsiella pneumoniae
Shigella flexneri
Pseudomonas aeroginosa
Streptococcus mutans
5.3 ± 0.4
3.8 ± 0.2
3.4 ± 0.3
4.6 ± 0.2
7.1 ± 0.3
6.4 ± 0.4
8.5 ± 0.2
6.6 ± 0.3
5.4 ± 0.2
8.3 ± 0.4
4.9 ± 0.3
5.2 ± 0.2
4.4 ± 0.4
3.7 ± 0.3
2.8 ± 0.4
1.1 ± 0.2
3.2 ± 0.3
4.8 ± 0.4
3.6 ± 0.3
3.8 ± 0.2
4.0 ± 0.4
2.5 ± 0.2
4.1 ± 0.3
1.3 ± 0.4
3.7 ± 0.3
2.7 ± 0.2
Values are mean ± SE.
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TABLE 5 | The antimicrobial activity of E. faecium CM33 against
pathogens.
Pathogenic microorganisms Source Supernatant
Clostridium difficile
Clostridium histolyticum
Staphylococcus aureus
Staphylococcus saprophyticus
Salmonella typhimurium
Candida albicans
Escherichia coli 0157
Bacillus cereus
Listeria monocytogenes
Klebsiella pneumoniae
Shigella flexneri
Pseudomonas aeroginosa
Streptococcus mutans
ATCC 43255
ATCC 19401
ATCC 25923
PTCC 1440
ATCC 14028
ATCC 10231
PTCC 1276
ATCC 11778
PTCC 1163
ATCC 10031
PTCC 1234
PTCC 1181
ATCC 35668
+
+
++
++
+
+++
++
++
+++
++
++
++
+
TABLE 6 | Detection of virulence-related genes in enterococcal strains
used in this research.
Strain Species Virulent genes
ATCC 29212
ATCC 51299
CM33
E. faecium
E. faecium
E. faecium
gelE, cylA
gelE, vanB, ccf, agg
None
interest on health-oriented nutritional habits. Bacteria generally
recognize as probiotic commonly belong to LAB. These
microorganisms, as commensals in the human gastrointestinal
tract, show a long history of use in foods and fermented products
(Haghshenas et al., 2014a,b, 2015; Nami et al., 2014a,b,c).
Enterococcus bacteria have various helpful functions in the dairy
industry (Haghshenas et al., 2014c; Nami et al., 2014d). As
starters, enterococci fulﬁll a considerable function in developing
ﬂavor progress and quality of cheeses. As probiotics, LAB are
able to be used for healing of gut disorders in both humans and
animals since these bacteria contribute to the intestinal health of
the host by the development of gut microbial balance (Rehaiem
et al., 2014). On the other hand, some requirements should be
fulﬁlled to introduce a certain strain as a probiotic (Collins et al.,
1998) and probiotic activities should be conﬁrmed in well-made
human studies. The aim of this paper was to evaluate safety and
the potential beneﬁcial properties of E. faecium CM33 isolated
from ewe colostrum.
The most important characteristics required for
microorganisms to be probiotics is their ability to survive
while passing through the upper digestive tract to reach the
large intestine, where their positive functions are predictable
(Bezkorovainy, 2001; Tuomola et al., 2001; Nueno-Palop and
Narbad, 2011). Probiotics can adhere to epithelial cells and
should tolerate high acidic pH and high bile salt conditions
in the gastric and intestinal ﬂuid. Resistance to acid is of the
popular properties used during the screening of potential
probiotic strains. Another important mechanism in resisting
intestinal pathogens and preventing diseases is the competition
of probiotic bacteria with pathogens to adhere and colonize
(Pascual et al., 2008). In this study, E. faecium CM33 isolated
from ewe coloctrum dairy products was capable to survive both
in bile salts and the gastric simulated digestion condition. This
strain was further evaluated for their adhesion ability to Caco-2
cells. Data showed that E. faecium CM33 possessed an ability to
resist the digestion conditions and was able to adhere to Caco-2
cells. These results show that E. faecium CM33 could be a suitable
candidate to be as potential new probiotic.
The production of antimicrobial compounds like bacteriocins,
organic acids, and hydrogen peroxide is of the well-designed
properties applied to characterize probiotics (Rehaiem et al.,
2014). Production of bacteriocins (enterocins) is the useful
biotechnological trait of Enterococcus bacteria (Franz et al., 2011).
The PCR results (Table 1; Figure 1) showed that E. faecium
CM33 carried enterocins A, 31, Q, and X structural genes, while
the other primers used in this test did not yield any visible
band. Franz et al. (2007) classiﬁed enterocins A and 31 in the
class IIa bacteriocins (pediocin-like bacteriocins). This group of
bacteriocins is cationic and shows very eﬀectual anti-Listeria
activity and permeabilizes the cell membrane to kills target cells.
Moreover, results showed that E. faecium CM33 has the greatest
inhibitory function against L. monocytogenes. This fact could be
described by the capability of Enterococcus bacteria to obtain and
replace genetic information by conjugation (Brandão et al., 2010),
FIGURE 1 | Amplification results for screening enterocin genes in Enterococcus faecium CM33. L, molecular weight ladder (kbp); N, negative control; P,
positive control by using purified DNA from a producer strain; Q, enterocin Q; 31: enterocin 31; A: enterocin A and X: enterocin X.
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not only between strains of Enterococcus genus, but also with
other genera (Strompfová et al., 2008).
The class IIb bacteriocins, two-peptide bacteriocins, also need
two diverse peptides (enterocins Q and X) for activity. The
production of multiple bacteriocins is not unusual and could
be a general aspect of enterococci. Many Enterococcus bacteria
are able to produce multiple bacteriocins, such as E. faecium
WHE81 (Ennahar et al., 2001), E. faecium KV-B5 (Hu et al.,
2010), E. faecium NKR-5-3A (Ishibashi et al., 2012), E. faecium
JCM 5804T (Park et al., 2003), and E. faecium DAC2 (Sánchez
et al., 2007). Nevertheless, the incidence of numerous enterocin
genes in enterococci does not forever link with an advanced
bacteriocin activity in their supernatants and not all enterocin
genes should be expressed at the same time (Casaus et al.,
1997).
Enterococcus faecium is the most normally occurring
enterococcal species in dairy industry (Morandi et al., 2006)
and fermented vegetable (Landeta et al., 2013). This species is
also found in raw fruits (Abriouel et al., 2008) and probiotic
preparations (Senok, 2009). However the nosocomial infections
related to wound, bacteraemia, urinary-tract infections, and
abdominal infections are caused by many enterococcal species
(Thurlow et al., 2009). Enterococcus bacteria, as pathogens, have
intrinsic and acquired resistance to many antibiotics that were
considered as a major concern. The resistance against antibiotics
and the production of virulence factors are two signiﬁcant factors
for the assessment of safety in enterococci. Probiotic strains may
harbor antibiotic resistance genes that are able to be transferred
to pathogenic bacteria. In particular, the most signiﬁcant concern
among antibiotic resistance is vancomycin resistance since it
is the last antibiotics largely eﬃcient against clinical infections
by multidrug-resistant pathogens (Klein, 2003). Several studies
elucidated the incidence of vancomycin-resistant enterococci in
food of animal origin, mainly in E. faecium and E. faecalis species;
although the isolation frequency seems to be lower than in clinical
samples (Klein, 2003). In our case, CM33 strain was found to be
susceptible to vancomycin, and this lack of resistance associated
with the absence of van A, van B and van C2 genes. According to
the EFSA, if the strain has one or more these genetic elements,
this strain is unsafe and could not be applied as a feed additive
(Ogier and Serror, 2008). Moreover, no resistance to other
antibiotics such as gentamycin, erythromycin, tetracycline, and
rifampicin was detected in this colostrum-isolated Enterococcus.
The potential pathogenicity of CM33 strain was evaluated
by assessing the existence of genes encoding for other virulence
factors, as determined by studies in various enterococcal species
(Omar et al., 2004). Genes encoding for cell-wall anchored
collagen adhesion (acm), aggregation substance (agg), cytolysin
(cylA), and gelatinase (gelE) were not found in our isolated strain.
Besides, the ampliﬁcation for a sex pheromones gene (ccf ), which
could be involved in initiating conjugation processes (Clewell,
2011) was negative.
One of important properties of strain to be as a potential
probiotic is anti-pathogen activity. In vitro test under neutralized
pH was performed using 13 pathogenic microorganisms and
supernatants (metabolites) obtained from the exponential
E. faecium CM33 culture. The well diﬀusion technique was
performed to evaluate the inhibitory eﬀect of the CM33
strain against 13 pathogenic microorganisms. The E. faecium
supernatant demonstrated the strong inhibition function against
indicator pathogens (Table 5). This strain was found to have
the strongest inhibition activity against L. monocytogenes and
Candida albicans. It was recommended that E. faecium CM33
produced bacteriocins (enterocin A and 31) to inhibit these
pathogens.
According to previous studies, the multiple enterocins-
producing isolate is likely more capable and could display a
wider range of inhibition in inhibiting the growth of undesirable
bacteria than a simple bacteriocin producer (Ishibashi et al.,
2012). E. faecium DAC2 (producer both Ent A and Ent P)
produces a higher antagonistic activity than those of the controls
E. faecium T136 and E. faecium P13 (producer of enterocin A and
enterocin P, respectively; Sánchez et al., 2007). The production of
bacteriocins by LAB helps LAB to be colonized in their habitats
and to compete with other bacteria (Garriga et al., 1993). Many
factors including decreased pH levels, competition for substrates,
and the production of substances such as bacteriocins are caused
the antimicrobial activity of LAB (Parente and Ricciardi, 1999).
The competitive inhibition of enteropathogen attachment to
epithelial cells by LAB is another important factor. So, the
competitive inhibition of adherence of pathogenic bacteria to
Caco-2 cells by adhering E. faecium CM33 cells was evaluated.
This strain was able to strongly inhibit the adhesion of many
tested pathogens (Table 4). However, the mechanisms by which
LAB inhibit pathogen adhesion to human cell lines in vitro
are not fully understood. Steric hindrance rather than blockage
of speciﬁc receptors may be involved (Bernet et al., 1993).
Additional trials are required to discover the exact mechanism
of inhibition observed in this study.
Conclusion
An identiﬁed strain of E. faecium from colostrum can present
interesting probiotic characteristics. It can stay alive during
passing the digestive system and has ability to be colonized
on the intestinal epithelial cells. In addition, this strain showed
a signiﬁcant enteropathogen growth inhibiting activity and
interference with pathogens adhesion to human colon Caco-
2 cells. These features could enable this strain to establish
itself in the intestinal tract and to compete with other bacterial
species. However, the safety and implications for public health
of individual enterococcal strains must be carefully evaluated to
fully exploit their industrial potential.
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